Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Thyora Therapeutics launches to build platform for covalent drug discovery
Base to Base biotech podcast 70: Taking the lead on GI motility disorders
Cancer immunotherapy and gene therapy in a single nanoparticle
New data from DM1 study
Synaptiq Therapeutics launches with acquisition of SYN-001 programme
Collaboration to develop first medicine for newly identified ReNU syndrome
Body’s natural recycling system could help reduce inflammation
Crystalys Therapeutics raises $130m for gout treatment